论文部分内容阅读
目的:探讨生长抑素和生长激素联合应用治疗重症急性胰腺炎的临床效果。方法:选取2014年6月~2015年6月在我院接受治疗的64例重症急性胰腺炎患者作为探讨对象,按照治疗方法的不同将其分为对照组和实验组,对照组患者采用生长抑素治疗,实验组患者采用生长抑素联用生长激素治疗,并比较两组患者临床治疗效果。结果:实验组患者腹痛和血淀粉酶等临床症状改善情况以及平均住院天数和并发症发生率明显优于对照组,两组比较差异具有统计学意义(p<0.05);治疗后,实验组患者总蛋白和白蛋白水平明显高于对照组,两组比较差异具有统计学意义(p<0.05)。结论:生长抑素和生长激素联合疗法在治疗重症急性胰腺方面临床效果明显,该方法具有临床推广应用价值。
Objective: To investigate the clinical effect of combination of somatostatin and growth hormone in the treatment of severe acute pancreatitis. Methods: Sixty-four patients with severe acute pancreatitis who were treated in our hospital from June 2014 to June 2015 were selected as the study subjects and divided into control group and experimental group according to different treatment methods. Patients in control group were treated with growth inhibition Su-treatment, the experimental group patients with somatostatin combined with growth hormone treatment, and compared the clinical efficacy of two groups of patients. Results: The improvement of clinical symptoms such as abdominal pain and blood amylase, as well as the average duration of hospitalization and complication in the experimental group were significantly better than those in the control group (P <0.05). After treatment, the patients in the experimental group Total protein and albumin levels were significantly higher than the control group, the difference between the two groups was statistically significant (p <0.05). Conclusion: Somatostatin and growth hormone combination therapy in the treatment of severe acute pancreatic clinical effect is obvious, the method has the clinical application value.